Leading A Diverse Company: Biopharma Executives Offer Ways Forward
Executive Summary
BIO hosted discussions during its annual meeting to reinforce the value of inclusion, offer advice to companies and reflect on recent US events.
You may also be interested in...
Nearly One Year Post-Celgene: BMS CMO On Pipeline Progress, Clinical Trial Diversity
Chief medical officer Samit Hirawat outlines R&D successes – though there have been some setbacks since it bought Celgene for $74bn last year – and the company’s commitment to clinical trial diversity.
10 Non-COVID News Updates To Listen For In Second Quarter Reporting
The pandemic is expected to dominate the industry's second quarter earnings calls, which kick off on 16 July, but here are 10 other topics to listen for.
Quick Listen: Scrip's Five Must-Know Things
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharma industry.
Need a specific report? 1000+ reports available
Buy Reports